Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Operating Margin: 2012-2025

Historic Operating Margin for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to 17.40%.

  • Veracyte's Operating Margin rose 703.00% to 17.40% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.00%, marking a year-over-year increase of 1053.00%. This contributed to the annual value of 3.62% for FY2024, which is 2738.00% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Operating Margin is 17.40%, which was up 529.93% from -4.05% recorded in Q2 2025.
  • In the past 5 years, Veracyte's Operating Margin registered a high of 17.40% during Q3 2025, and its lowest value of -123.74% during Q1 2021.
  • Its 3-year average for Operating Margin is -5.82%, with a median of -4.05% in 2025.
  • In the last 5 years, Veracyte's Operating Margin crashed by 8,454bps in 2021 and then skyrocketed by 10,124bps in 2022.
  • Quarterly analysis of 5 years shows Veracyte's Operating Margin stood at -18.32% in 2021, then skyrocketed by 1,157bps to -6.75% in 2022, then slumped by 2,941bps to -36.16% in 2023, then spiked by 3,968bps to 3.52% in 2024, then soared by 703bps to 17.40% in 2025.
  • Its Operating Margin was 17.40% in Q3 2025, compared to -4.05% in Q2 2025 and 2.54% in Q1 2025.